Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3546432 | 1.00 | ALDH1A1 (0.48) | ALDH1A1EPHX1HIF1ACES2CES1 | |
| SCHEMBL249058 | 1.00 | — | — | |
| SCHEMBL18713185 | 1.00 | ALDH1A1 (0.48) | ALDH1A1EPHX1HIF1ACES2CES1 | |
| SCHEMBL3542888 | 1.00 | ALDH1A1 (0.48) | ALDH1A1EPHX1HIF1ACES2CES1 | |
| SCHEMBL19590919 | 1.00 | ALDH1A1 (0.48) | ALDH1A1EPHX1HIF1ACES2CES1 | |
| SCHEMBL14456664 | 1.00 | ALDH1A1 (0.48) | ALDH1A1EPHX1HIF1ACES2CES1 | |
| SCHEMBL3195805 | 1.00 | ALDH1A1 (0.48) | ALDH1A1EPHX1HIF1ACES2CES1 | |
| SCHEMBL3544633 | 1.00 | ALDH1A1 (0.48) | ALDH1A1EPHX1HIF1ACES2CES1 | |
| SCHEMBL3542649 | 1.00 | — | — | |
| SCHEMBL279393 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8623967-B2 | Polymers functionalized with nitroso compounds | BRIDGESTONE CORPORATION (JP) | 2014-01-07 | — | — | US | claimed |
| US-20130096264-A1 | POLYMERS FUNCTIONALIZED WITH NITROSO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2013-04-18 | — | — | US | claimed |
| US-8188195-B2 | Polymers functionalized with nitroso compounds | BRIDGESTONE CORPORATION (JP) | 2012-05-29 | — | — | US | claimed |
| US-20100168378-A1 | POLYMERS FUNCTIONALIZED WITH NITROSO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2010-07-01 | — | — | US | claimed |
| US-9670299-B2 | Polymers functionalized with nitroso compounds | BRIDGESTONE CORPORATION (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20160032030-A1 | POLYMERS FUNCTIONALIZED WITH NITROSO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2016-02-04 | — | — | US | disclosed |
| US-9127100-B2 | Polymers functionalized with nitroso compounds | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20140221630-A1 | METHOD AND SYSTEM FOR PROCESSING OF AQUATIC SPECIES | PA LLC (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140100340-A1 | POLYMERS FUNCTIONALIZED WITH NITROSO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2014-04-10 | — | — | US | disclosed |
| US-8623967-B2 | Polymers functionalized with nitroso compounds | BRIDGESTONE CORPORATION (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20130096264-A1 | POLYMERS FUNCTIONALIZED WITH NITROSO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2013-04-18 | — | — | US | disclosed |
| EP-1854792-B1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-8188195-B2 | Polymers functionalized with nitroso compounds | BRIDGESTONE CORPORATION (JP) | 2012-05-29 | — | — | US | disclosed |
| US-7820693-B2 | 1-(2H)-isoquinolone derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20100168378-A1 | POLYMERS FUNCTIONALIZED WITH NITROSO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2010-07-01 | — | — | US | disclosed |
| EP-2130583-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2009-12-09 | — | — | EP | disclosed |
| US-20090030195-A1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1854792-A1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030195-A1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | NQO1, NR5A1, SRD5A1 | ALDH1A1 371/4885EPHX1 584/4885HIF1A 1654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.